Skip to main content
Clinical Trials/NCT06006572
NCT06006572
Enrolling by Invitation
N/A

Direct Anterior Approach of the Hip and Variations in Wound Complications Using Different Closure Techniques

Rothman Institute Orthopaedics1 site in 1 country172 target enrollmentMarch 1, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Total Hip Replacement
Sponsor
Rothman Institute Orthopaedics
Enrollment
172
Locations
1
Primary Endpoint
Participant satisfaction
Status
Enrolling by Invitation
Last Updated
2 years ago

Overview

Brief Summary

This study aims to analyze the difference in rates of wound complications using two different closure techniques in Direct anterior approach for primary total hip replacement.

Detailed Description

The use of the direct anterior approach (DAA) for primary total hip arthroplasty (THA) has been increasingly popular but there has been a reported increased risk of wound complications compared with a posterior approach. Wound complications can lead to increased length of stay, reoperation procedures (i.e., irrigation and debridement), patient dissatisfaction, extra visits, readmissions, increased risk of periprosthetic joint infection and overall increased costs.

Registry
clinicaltrials.gov
Start Date
March 1, 2023
End Date
October 30, 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients older than 18 years old that will undergo THA via DAA

Exclusion Criteria

  • Previous hip arthroplasty surgeries or scars
  • THA secondary to oncologic or traumatic etiologies
  • uncontrolled diabetes (measured by a Hgb A1c above 8)
  • reported allergy to skin adhesive

Outcomes

Primary Outcomes

Participant satisfaction

Time Frame: 90 days

assessed using the POSAS (patient and observer scar assessment scale) questionnaire

Wound complications

Time Frame: 90 days

Assessed using photographic documentation of the wound

Study Sites (1)

Loading locations...

Similar Trials